Form 4: HealthStream Director Linda Rebrovick Increases Stake Through RSU Vesting

HealthStream Inc. Director Linda Rebrovick acquired 2,132 shares of common stock on June 9, 2025, through the vesting of restricted share units, bringing her total direct beneficial ownership to 58,181 shares.

Summary

• Linda Rebrovick, a Director at HealthStream Inc. (HSTM), acquired 2,132 shares of common stock on June 9, 2025.
• These shares were obtained at a price of $0 per share, resulting from the vesting of restricted share units (RSUs).
• Following this transaction, Ms. Rebrovick's direct beneficial ownership of HealthStream common stock increased to 58,181 shares.
• The vested RSUs included 1,126 units from a grant subject to a three-year vesting schedule that commenced annually on June 6, 2024.
• Additionally, 1,006 units from another RSU grant, with a three-year annual vesting schedule beginning May 30, 2025, also vested.
• After these conversions, Ms. Rebrovick retains 3,138 unvested restricted share units.

Sentiment

Score: 6

Explanation: The document reports a routine insider transaction (vesting of RSUs) which is generally neutral but can be seen as slightly positive as it increases insider ownership and aligns interests. There are no negative implications or significant new information to alter overall sentiment.

Positives

• Director Linda Rebrovick increased her direct beneficial ownership of HealthStream common stock by 2,132 shares, which aligns her interests more closely with those of shareholders.
• The acquisition of shares through RSU vesting at a $0 price is a standard component of equity compensation, reflecting the company's long-term incentive structure for its directors.

Negatives

• No explicit negatives are present in this Form 4 filing, as it primarily reports a routine equity compensation event.

Future Outlook

This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance or strategic outlook, focusing solely on an insider's equity transaction.

Industry Context

This Form 4 filing reports a routine insider transaction related to equity compensation, which is common across all industries. It does not provide specific insights into broader industry trends or competitive dynamics within the healthcare technology sector where HealthStream operates.

Comparison to Industry Standards

• This document reports an individual insider's equity compensation event, which is standard practice for publicly traded companies.
• It does not contain financial results or operational metrics that would allow for a direct comparison to global benchmarks or specific comparable companies/projects.
• The vesting of restricted stock units at a $0 exercise price is a typical mechanism for long-term incentive plans for directors and executives across various industries.

Stakeholder Impact

• Shareholders: The increase in director ownership aligns the director's interests more closely with those of shareholders, potentially signaling confidence in the company's long-term prospects.
• Employees: Not directly impacted by this specific director transaction.
• Customers: Not directly impacted by this specific director transaction.
• Suppliers: Not directly impacted by this specific director transaction.
• Creditors: Not directly impacted by this specific director transaction.

Next Steps

• The document does not outline specific future actions or milestones for the company, as it is a report of a past transaction.

Key Dates

Recommendation

Keywords

HealthStream Inc., HSTM, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Share Units, RSU Vesting, Director Stock Ownership, Equity Compensation